IRVINE, Calif. & BOONE, N.C.--(BUSINESS WIRE)--Jan. 13, 2016--
Masimo
(NASDAQ: MASI) and Appalachian Regional Healthcare System announced that
Watauga Medical Center in Boone is the first hospital in North Carolina
to install Masimo Patient SafetyNet, a remote monitoring and clinician
notification system, and Radius-7, a patient-worn monitor that is
designed to allow for patient mobility along with continuous monitoring.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160113005387/en/
“We are always looking for cutting-edge technologies focused on patient
safety,” said Richard Sparks, President & CEO, Appalachian Regional
Healthcare System. “We wanted a system that provides continuous
monitoring that wasn’t restricted to the patient’s room. The Radius-7
combined with Patient SafetyNet allows us the ability to keep a close
eye on our patients 24/7.”
Continuous patient surveillance with Patient SafetyNet has been shown to
reduce the need for rescue events and intensive care unit transfers in
hospitals and, as a result, can reduce costs related to these events.1,2
When changes occur in the measured values, which may indicate
deterioration in the patient’s condition, in addition to bedside alerts,
the alert also shows in the Telemetry room and nurse’s stations. This
allows the telemetry technician to contact the unit where the alarm is
happening immediately. Masimo Patient SafetyNet works in conjunction
with Masimo beside monitors and the Radius-7 wearable monitor to provide
wireless, continuous and non-invasive monitoring of oxygenation, pulse
rate and respiration, among other parameters.
Appalachian Regional Healthcare System’s Charles A. Cannon, Jr. Memorial
Hospital also recently implemented continuous monitoring. At this
location, the monitors are connected to the patient call system. When an
alert goes off, it sounds through the call lights and then sends a
message to the nurse’s station call monitor.
“Watauga Medical Center in Boone and Cannon Memorial Hospital in
Linville understand the importance of patient safety,” said Joe Kiani,
Founder and CEO of Masimo. “We are excited to see more and more
hospitals implement continuous monitoring of their patients in
post-surgical wards, as part of their patient safety protocols.”
@MasimoInnovates
| #Masimo
1 Taenzer A.H., Pyke J.B., McGrath S.P., Blike G.T. Anesthesiology.
2010 Feb; 112(2):282-7.
2 Taenzer A, Blike G, McGrath S,
Pyke J, Herrick M, Renaud C, Morgan J. “Postoperative Monitoring - The
Dartmouth Experience.” Anesthesia Patient Safety Foundation Newsletter
Spring-Summer 2012. Available online.
About Appalachian Regional Healthcare System
Appalachian Regional Healthcare System (ARHS), the healthcare leader in
the High Country, is comprised of two hospitals - Charles
A. Cannon, Jr. Memorial Hospital in Linville and Watauga
Medical Center in Boone - a physician practice management group - Appalachian
Regional Medical Associates (ARMA) - the Blowing
Rock Rehabilitation & Davant Extended Care Center in Blowing Rock
- and Appalachian
Regional Healthcare Foundation. Appalachian Regional Healthcare
System stays committed to promoting health in the High Country,
enhancing quality of life and simply “making life better.” This
charge makes Appalachian Regional Healthcare System the premier
healthcare system in this region. For more information, visit www.apprhs.org.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. The benefits of Masimo SET® have
been proven in more than 100 independent and objective studies and it is
estimated to be used on more than 100 million patients in leading
hospitals and other healthcare settings around the world. In 2005,
Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing
noninvasive and continuous monitoring of blood constituents that
previously could only be measured invasively, including total hemoglobin
(SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and more recently, Pleth Variability Index
(PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate,
and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive
patient monitoring and connectivity platform designed to speed the pace
of innovation and reduce the cost of care. Masimo is also taking an
active leadership role in mHealth with products such as the MightySat™
fingertip pulse oximeter. Additional information about Masimo and its
products may be found at www.masimo.com.
Forward-Looking Statements
This press release includes forward-looking statements as defined in
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, in connection with the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements are based on current expectations about future events
affecting us and are subject to risks and uncertainties, all of which
are difficult to predict and many of which are beyond our control and
could cause our actual results to differ materially and adversely from
those expressed in our forward-looking statements as a result of various
risk factors, including, but not limited to: risks related to our belief
that Masimo's unique noninvasive measurement technologies contribute to
positive clinical outcomes and patient safety; risks related to our
belief that Masimo noninvasive medical breakthroughs provide
cost-effective solutions with comparable accuracy and unique advantages;
as well as other factors discussed in the "Risk Factors" section of our
most recent reports filed with the Securities and Exchange Commission ("SEC"),
which may be obtained for free at the SEC's website at www.sec.gov.
Although we believe that the expectations reflected in our
forward-looking statements are reasonable, we do not know whether our
expectations will prove correct. All forward-looking statements included
in this press release are expressly qualified in their entirety by the
foregoing cautionary statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of
today's date. We do not undertake any obligation to update, amend or
clarify these statements or the "Risk Factors" contained in our most
recent reports filed with the SEC, whether as a result of new
information, future events or otherwise, except as may be required under
the applicable securities laws.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160113005387/en/
Source: Masimo
Watauga Medical Center
Media Contact:
Gillian Baker
828-268-8958
gbaker@apprhs.org
or
Masimo
Media
Contact:
Irene Paigah
858-859-7001
irenep@masimo.com